全球人工水晶體 (IOL) 市場 - 市場規模（按細分市場）、份額、監管、報銷、治療、預測（~2033 年）

視力障礙嚴重影響成年人的生活品質。 患有視力障礙的成年人的勞動參與率和生產力往往較低。 對於老年人來說，視力受損可能會導致社會孤立、行走困難、跌倒和骨折的風險更高，以及提前入住療養院或護理機構的可能性增加。 隨著人口的成長和老化，預計會有更多的人面臨更大的視力障礙風險。

本報告研究和分析了全球人工水晶體 (IOL) 市場，並提供了有關每個細分市場的市場規模、市場趨勢、競爭格局以及 COVID-19 影響的資訊。

市場模型的主要內容如下。

已上市的人工水晶體 (IOL) 和不斷變化的競爭格局

• 對主要產業趨勢的考慮
• 人工水晶體 (IOL) 市場年收入和市場前景（按細分市場）（2015-2033 年）
• 按細分市場劃分的手術總數、單位數量、平均售價和市場價值的詳細數據

全球、區域和國家層面的特定市場考量

• 按地區細分全球趨勢的特定市場定性資訊和國家/地區考慮因素
• 人工水晶體 (IOL) 市場的 SWOT 分析
• 人工水晶體 (IOL) 市場競爭動態的考量與趨勢

透過對醫療保健系統的真實、全面的了解來促進市場了解。 市場進入部分還提供有關報銷政策和監管環境的信息，使您能夠更深入地研究市場動態。

• 各國醫療保健系統概覽
• 按國家/地區劃分的報銷政策
• 各國醫療科技監理狀況

目標公司

• Alcon Inc
• Johnson & Johnson
• Hoya Corp
• Carl Zeiss Stiftung AG
• Bausch Health Companies Inc
• STAAR Surgical Company
• 其他

Abstract

Intraocular Lens (IOL) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Ophthalmic Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Intraocular Lens (IOL) market for the year 2020 and beyond. Vision impairment severely impacts quality of life among adult populations. Adults with vision impairment often have lower rates of workforce participation and productivity. In the case of older adults, vision impairment can contribute to social isolation, difficulty walking, a higher risk of falls and fractures, and a greater likelihood of early entry into nursing or care homes. Population growth and ageing are expected to increase the risk that more people acquire vision impairment.

Refractive surgery options for vision correction range from corneal reshaping with lasers to surgical insertion of artificial lenses. Cataracts can be corrected with a procedure that is performed more than 3 million times a year in the United States. Cataract surgery is an operation to remove the eye lens when it is cloudy. The purpose of the lens is to refract light rays that come into the eye to help one see. The only way to remove a cataract is with surgery. During cataract surgery, the cloudy natural lens is removed and replaced with a clear artificial lens. That lens is called an Intraocular Lens (IOL).

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Intraocular Lens (IOL) and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Intraocular Lens (IOL) market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Intraocular Lens (IOL) market.
• Competitive dynamics insights and trends provided for Venous Stents market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Alcon Inc, Johnson & Johnson, Hoya Corp, Carl Zeiss Stiftung AG, Bausch Health Companies Inc, STAAR Surgical Company, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Intraocular Lens (IOL) marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Intraocular Lens (IOL) market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Intraocular Lens (IOL) market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Intraocular Lens (IOL) market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Intraocular Lens (IOL) market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable

List of Tables

Not Applicable

List of Figures

Not Applicable